Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Spironolactone for prevention of perioperative atrial fibrillation after cardiac surgery
2018-000263-92Phase 3Completed
- Sponsor
- CHU Caen Normandie
- Start
- Mar 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Atrial fibrillation (AFib) comparing Spironolactone with Placebo (2 arms). Primary endpoint: Occurrence of postoperative atrial fibrillation. Started Mar 2018; status: completed.
02
Drugs
spironolactone
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on 2018-000263-92.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-000263-92.